2.685
price down icon0.74%   -0.025
 
loading

Perché le azioni Gain Therapeutics Inc (GANX) sono in ribasso?

Abbiamo notato un calo di 5.17% nelle azioni di Gain Therapeutics Inc (GANX) durante la sessione di negoziazione di 2026-03-03. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-21:

Gain Therapeutics Inc Stock (GANX) dropped by 23.90% from $2.72 to $2.07 in the trading on Tuesday November 21, 2023. The reason why GANX stock down today is due to the announcement of public offering. Gain Therapeutics has announced pricing of $9.4 million public offering of 2,213,044 shares at $2.005/share and accompanying warrants. In connection with the offering, Gain has granted the underwriters a 30-day option to purchase up to an additional 15% of shares of common stock and/or warrants

$98.89
price down icon 1.19%
$51.05
price down icon 3.39%
$47.52
price down icon 0.08%
$103.83
price down icon 3.34%
$148.00
price up icon 1.03%
biotechnology ONC
$300.59
price down icon 4.91%
Capitalizzazione:     |  Volume (24 ore):